Gentian Diagnostics AS (OSL:GENT) Scaled Net Operating Assets : 0.63 (As of Dec. 2024)

View and export this data going back to 2016. Start your Free Trial

What is Gentian Diagnostics AS Scaled Net Operating Assets?

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Gentian Diagnostics AS's operating assets for the quarter that ended in Dec. 2024 was kr144.9 Mil. Gentian Diagnostics AS's operating liabilities for the quarter that ended in Dec. 2024 was kr25.6 Mil. Gentian Diagnostics AS's Total Assets for the quarter that ended in Sep. 2024 was kr189.1 Mil. Therefore, Gentian Diagnostics AS's scaled net operating assets (SNOA) for the quarter that ended in Dec. 2024 was 0.63.

Gentian Diagnostics AS Scaled Net Operating Assets Historical Data

The historical data trend for Gentian Diagnostics AS's Scaled Net Operating Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Gentian Diagnostics AS Scaled Net Operating Assets Chart

Gentian Diagnostics AS Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Scaled Net Operating Assets

Get a 7-Day Free Trial

0.26

0.33

0.42

0.38

0.66

Gentian Diagnostics AS Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Scaled Net Operating Assets	Get a 7-Day Free Trial															0.38	0.41	0.45	0.40	0.63

Competitive Comparison of Gentian Diagnostics AS's Scaled Net Operating Assets

For the Medical Devices subindustry, Gentian Diagnostics AS's Scaled Net Operating Assets, along with its competitors' market caps and Scaled Net Operating Assets data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Gentian Diagnostics AS's Scaled Net Operating Assets Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Gentian Diagnostics AS's Scaled Net Operating Assets distribution charts can be found below:

* The bar in red indicates where Gentian Diagnostics AS's Scaled Net Operating Assets falls into.

Save Embed

;

Save Embed

;

Gentian Diagnostics AS Scaled Net Operating Assets Calculation

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Gentian Diagnostics AS's Scaled Net Operating Assets (SNOA) for the fiscal year that ended in Dec. 2024 is calculated as

	Scaled Net Operating Assets (SNOA)		(A: Dec. 2024 )
=	(Operating Assets (A: Dec. 2024 )	-	Operating Liabilities (A: Dec. 2024 ))	/	Total Assets (A: Dec. 2023 )
=	(144.926	-	25.575)	/	181.038
=	0.66

where

	Operating Assets		(A: Dec. 2024 )
=	Total Assets	-	Cash, Cash Equivalents, Marketable Securities
=	229.664	-	84.738
=	144.926

	Operating Liabilities		(A: Dec. 2024 )
=	Total Liabilities	-	Long-Term Debt & Capital Lease Obligation	-	Short-Term Debt & Capital Lease Obligation
=	35.614	-	5.507	-	4.532
=	25.575

Gentian Diagnostics AS's Scaled Net Operating Assets (SNOA) for the quarter that ended in Dec. 2024 is calculated as

	Scaled Net Operating Assets (SNOA)		(Q: Dec. 2024 )
=	(Operating Assets (Q: Dec. 2024 )	-	Operating Liabilities (Q: Dec. 2024 ))	/	Total Assets (Q: Sep. 2024 )
=	(144.926	-	25.575)	/	189.097
=	0.63

where

	Operating Assets		(Q: Dec. 2024 )
=	Total Assets	-	Cash, Cash Equivalents, Marketable Securities
=	229.664	-	84.738
=	144.926

	Operating Liabilities		(Q: Dec. 2024 )
=	Total Liabilities	-	Long-Term Debt & Capital Lease Obligation	-	Short-Term Debt & Capital Lease Obligation
=	35.614	-	5.507	-	4.532
=	25.575

Gentian Diagnostics AS Scaled Net Operating Assets Related Terms

Thank you for viewing the detailed overview of Gentian Diagnostics AS's Scaled Net Operating Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

Gentian Diagnostics AS Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Gentian Diagnostics AS (OSL:GENT) » Definitions » Scaled Net Operating Assets

Comparable Companies

Traded in Other Exchanges

N/A

Address

Bjornasveien 5, Moss, NOR, 1596

Website

https://www.gentian.com

Gentian Diagnostics AS operates as a medical diagnostics company in Norway. It develops and produces in-vitro diagnostic reagents (IVD) for use in medical diagnostics and research. Its portfolio and pipeline of reagents span areas of inflammations, severe infections, kidney diseases, heart failures, and veterinary healthcare. The company's product portfolio includes the Gentian Cystatin C Immunoassay, the GCAL circulating calprotectin immunoassay (IVDR), the Gentian Retinol Binding Protein (RBP), and the Gentian Canine CRP among others. Geographically, it generates a majority of its revenue from Europe followed by Asia and the United States of America.